Pi-Cardia

📣 𝗦𝗵𝗼𝗿𝘁𝗖𝘂𝘁 – 𝗧𝗵𝗲 𝗙𝗶𝗿𝘀𝘁 𝗗𝗲𝗱𝗶𝗰𝗮𝘁𝗲𝗱 𝗟𝗲𝗮𝗳𝗹𝗲𝘁 𝗠𝗼𝗱𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻 𝗶𝘀 𝗡𝗼𝘄 𝗙𝗗𝗔 𝗖𝗹𝗲𝗮𝗿𝗲𝗱! Addressing lifetime management of aortic stenosis with a safe, simple and effective solution 🫀 . . . . #PiCardia #ShortCut #TAVI #TAVR #AorticValve #AorticStenosis #ValveinValve #VIV #Innovation #StructuralHeart #LifetimeManagement #LifetimeManagementofAS #percutaneoustreatment #transcatheter #leafletsplitting #medtech #startuphealth #coronaryobstruction #coronaryaccess #leafletmodification #valvefailure #mechanicalsplitting #valves #TAVRenabler #FDACleared TCTMD PCR Edwards Lifesciences Medtronic Abbott Boston Scientific EACTS - European Association for Cardio-Thoracic Surgery American College of Cardiology American Heart Association

🚨 𝗕𝗥𝗘𝗔𝗞𝗜𝗡𝗚 𝗡𝗘𝗪𝗦 🚨 We are thrilled to announce that 𝗣𝗶-𝗖𝗮𝗿𝗱𝗶𝗮 𝗵𝗮𝘀 𝗿𝗲𝗰𝗲𝗶𝘃𝗲𝗱 𝗙𝗗𝗔 𝗺𝗮𝗿𝗸𝗲𝘁 𝗰𝗹𝗲𝗮𝗿𝗮𝗻𝗰𝗲 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗦𝗵𝗼𝗿𝘁𝗖𝘂𝘁 device! 🎉 This is a huge milestone, as we believe ShortCut will be a game-changing leaflet modification solution for the lifetime management of patients with aortic stenosis, addressing coronary obstruction prior to implanting a TAVR. 🫀 Thank you to everyone for your ongoing support, collaboration, and partnership in helping us reach this great achievement! 👏🏻 The full press release can be found in the below link: https://lnkd.in/dmTf8nXf Danny Dvir Didier Tchetche Susheel Kodali Philippe Généreux Benjamin Seguy Philippe Pibarot Hemal Gada Tamim Nazif, MD David Hildick-Smith Nicolas Dumonteil Axel Unbehaun thomas modine Brian Whisenant Christophe Caussin Thomas E. Waggoner, DO, FACC, FSCAI, FSVM, RPVI Jacob Mishell Stanley Chetcuti Saibal Kar Molly Szerlip Ravi Ramana Ran Kornowski Ulrich Gerckens Paolo Denti Ternacle Julien Sabah Skaf MD Jan Kovac Hasan Jilaihawi Vivek Patel Rami Ju'beh Pradeep Yadav Vinod Thourani Edwards Lifesciences Medtronic Abbott Boston Scientific TCTMD PCR EACTS - European Association for Cardio-Thoracic Surgery American College of Cardiology American Heart Association . . . #PiCardia #ShortCut #TAVI #TAVR #AorticValve #AorticStenosis #ValveinValve #VIV #Innovation #StructuralHeart #LifetimeManagement #LifetimeManagementofAS #percutaneoustreatment #transcatheter #leafletsplitting #medtech #startuphealth #coronaryobstruction #coronaryaccess #leafletmodification #valvefailure #mechanicalsplitting #valves #TAVRenabler 

Congrats to the Heart Team at UPMC Harrisburg for performing their first 𝗦𝗵𝗼𝗿𝘁𝗖𝘂𝘁 case in the 𝗖𝗼𝗻𝘁𝗶𝗻𝘂𝗲𝗱 𝗔𝗰𝗰𝗲𝘀𝘀 𝗦𝘁𝘂𝗱𝘆! 🎉 As usual, a flawless and elegant procedure performed by Dr. Hemal Gada and his team. The patient had a challenging anatomy with a failed 27 mm Hancock II valve and was at risk of left coronary obstruction, which was split with ShortCut in 1️⃣5️⃣ mins. ShortCut enabled a safe TAVR procedure with 29 mm Evolut FX+. We thank the investigators and the whole research team for their passion, professionalism, and the patients for their trust. ✨ Hemal Gada Nathan Melton Atizaz Mansoor, MD Arun Kanmanthareddy Eric Cheek Gary Gratson Sophie Meewis Yael Kislev #PiCardia #ShortCut #TAVI #TAVR #AorticValve #AorticStenosis #ValveinValve #VIV #Innovation #StructuralHeart #LifetimeManagement #LifetimeManagementofAS #percutaneoustreatment #transcatheter #leafletsplitting #medtech #startuphealth #coronaryobstruction #coronaryaccess #leafletmodification #valvefailure #mechanicalsplitting #valves #degeneratedvalve

Congratulations to Dr. Raj Makkar and the #HeartTeam at Cedars-Sinai for performing their first ShortCut case in the Continued Access Study! 👏 The patient had a failed Magna Ease valve and was at high risk of coronary obstruction. It was a smooth procedure with a dual split of both the LCC and RCC leaflets in ~20 mins, enabling a safe TAVR with a 23mm #SAPIEN3. . . . @Raj Makkar, MD, Aakriti Gupta, MD MSc, Tarun Chakravarty @Dhairya Patel, MD, Hasan Jilaihawi, Moody Makar, @Wen Cheng, MD, Hardip Thakerar, Eric Cheek #PiCardia #ShortCut #TAVI #TAVR #AorticValve #AorticStenosis #ValveinValve #VIV #Innovation #StructuralHeart #LifetimeManagement #LifetimeManagementofAS #percutaneoustreatment #transcatheter #leafletsplitting #medtech #startuphealth #coronaryobstruction #coronaryaccess #leafletmodification #valvefailure #mechanicalsplitting #valves #degeneratedvalve

Excellent #ShortCut Continued Access Case at Los Robles Hospital and Medical Center! 💥 TAV-in-TAV procedure in an 88 y.o. female with O2 dependent refractory heart failure and a failed #Evolut Pro 26mm valve seven years post index procedure, with significant risk of coronary obstruction. The team successfully performed a ShortCut procedure with a dual leaflet split of the LCC & RCC leaflets, enabling safe TAVR with a 23 mm #SAPIEN 3 Ultra with Resilia valve. As the wave of TAV-in-TAV starts to hit, having a safe and predictable device, like ShortCut, will be critical for these challenging cases. 💡 Congratulations to the Heart Team at Los Robles! 👏 Saibal Kar Gregory P. Fontana, MD, FACC, FACS Hardip Thakerar Eric Cheek Gary Gratson Sophie Meewis #PiCardia #ShortCut #TAVI #TAVR #AorticValve #AorticStenosis #ValveinValve #VIV #Innovation #StructuralHeart #LifetimeManagement #LifetimeManagementofAS #transcatheter #leafletsplitting #medtech #startuphealth #coronaryobstruction #coronaryaccess #leafletmodification #valvefailure #mechanicalsplitting #valves  

Leading the way in leaflet modification, the #ShortCut Pivotal Study has made significant strides in the field. Recently published in the European Heart Journal, the study highlights the innovative approach and promising results achieved with ShortCut. ✨ Key findings from the study include: ✅ 𝗦𝘁𝗿𝗼𝗻𝗴 𝐒𝐚𝐟𝐞𝐭𝐲 𝐏𝐫𝐨𝐟𝐢𝐥𝐞: The primary safety endpoint was met with 0% procedural mortality and only 1.7% stroke. ✅ 𝐄𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞𝐧𝐞𝐬𝐬: The primary effectiveness endpoint was met by achieving a remarkable 100% success rate in per patient leaflet splitting. These results underscore the potential of ShortCut as a transformative technique in leaflet modification, offering a safe and effective solution for the lifetime management of patients requiring multiple valve treatments. If you missed the details, be sure to check out the full publication in the link below 👇 https://lnkd.in/dJsu7PHU . . . . . Danny Dvir Didier Tchetche Susheel Kodali Philippe Généreux Benjamin Seguy Philippe Pibarot Hemal Gada Tamim Nazif, MD David Hildick-Smith Nicolas Dumonteil Axel Unbehaun thomas modine Brian Whisenant Christophe Caussin Thomas E. Waggoner, DO, FACC, FSCAI, FSVM, RPVI Jacob Mishell Stanley Chetcuti Saibal Kar Molly Szerlip Ravi Ramana Itsik Ben-Dor Ran Kornowski Ron Waksman Ulrich Gerckens Paolo Denti Ternacle Julien Sabah Skaf MD Jan Kovac Hasan Jilaihawi Vivek Patel Rami Ju'beh #PiCardia #ShortCut #TAVI #TAVR #AorticValve #AorticStenosis #ValveinValve #VIV #Innovation #StructuralHeart #LifetimeManagement #LifetimeManagementofAS #percutaneoustreatment #transcatheter #leafletsplitting #medtech #startuphealth #coronaryobstruction #coronaryaccess #leafletmodification #valvefailure #mechanicalsplitting #valves #TAVRenabler #Splitwithconfidence 

Following the successful completion of our Global ShortCut Pivitol study, we are absolutely thrilled to announce the launch of our Continued Access study for ShortCut in the U.S. 🚀 A huge shoutout to Dr. Saibal Kar, Dr. Gregory P. Fontana, MD, FACC, FACS, and the amazing team at 🏥 Los Robles Hospital and Medical Center for kicking off this new chapter. They performed the first two ShortCut cases in the study on patients with very challenging anatomies, including failed Trifecta and Magna Ease valves at risk of coronary obstruction. Both patients were treated successfully with a dual leaflet split using the ShortCut device, enabling a safe TAVR. This expansion of our clinical program allows us to gather even more valuable insights. Here’s to reaching more patients and making a difference! ✨ . . . Pi-Cardia Eric Cheek Gary Gratson Christoph Lesser Hardip Thakerar #PiCardia #ShortCut #TAVI #TAVR #AorticValve #AorticStenosis #ValveinValve #VIV #Innovation #StructuralHeart #LifetimeManagement #LifetimeManagementofAS #percutaneoustreatment #transcatheter #leafletsplitting #medtech #startuphealth #coronaryobstruction #coronaryaccess #leafletmodification #valvefailure #mechanicalsplitting #valves #TAVRenabler #Splitwithconfidence #ShortCutPivotalStudy #ShortCutCAS

#SWAC TONIGHT: ShortCut vs BASILICA Join us for SWAC tonight @5pm PST/8pm EST for an informative data update on one of the most exciting tools in the SHD community for TAVR facilitatation during VIV deployment! We have guest co-moderators Drs. Philippe Genereaux and Susheel Kodali discussing unmet clinical needs and what the space looks like in the next 10-years! #Shortcut Philippe Généreux Kodali Susheel Tucson Medical Center https://lnkd.in/ghE-SvCz

Leaflet modification is key for the lifetime management of patients requiring multiple valve interventions 🫀 ✅ Annual ViV is projected to reach ~42k US procedures in 2035 (~15% of all TAVR). ✅ With increased TAVR usage, total annual TAVR-in-TAVR is expected to overtake TAVR-in-SAVR by 2028. Congratulations to the authors on this important article! 👏 https://lnkd.in/du6vHPmJ Philippe Généreux Roy Dar Rishi Puri Yoseph Rozenman Molly Szerlip Pradeep Yadav Vinod Thourani Philippe Pibarot Danny Dvir Susheel Kodali Didier Tchetche Benjamin Seguy Paolo Denti Saibal Kar Ulrich Gerckens Medtronic Cardiac and Vascular Edwards Surgical Structural Heart Therapies Abbott | Cardiovascular Boston Scientific Cardiology CRF PCR #PiCardia #ShortCut #TAVI #TAVR #AorticValve #AorticStenosis #ValveinValve #VIV #Innovation #StructuralHeart #LifetimeManagement #LifetimeManagementofAS #percutaneoustreatment #transcatheter #leafletsplitting #medtech #startuphealth #coronaryobstruction #coronaryaccess #leafletmodification #valvefailure #mechanicalsplitting #valves

With an expected rise in redo TAVI and valve-in-valve procedures, there is heightened interest in technologies that can help to facilitate coronary access and prevent obstruction resulting from the treatment. At PCR London Valves, Didier Tchetche presented details of the ShortCut pivotal trial, outlining details of one such device aimed at addressing this need.